Vinyl chloride-NAFLD interaction

氯乙烯-NAFLD 相互作用

基本信息

  • 批准号:
    9729273
  • 负责人:
  • 金额:
    $ 4.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

Obesity and its metabolic complications are highly prevalent and are major health problems in the United States and worldwide. Indeed, obesity may influence individual susceptibility to other environmental exposures such as vinyl chloride (VC). Specifically, we hypothesize that experimental NAFLD and the consumption of certain types of dietary fat such as poly-unsaturated fatty acids (PUFA) sensitize the liver to VC as a 2nd hit. We therefore propose that that LA metabolites sensitize the liver to VC hepatotoxicity via molecular, organelle, and cellular VC effects (NAFLD mechanisms). Aim 1. Evaluate the role of OXLAMs in VC-enhanced hepatocyte death in an animal model of NAFLD. Specifically, we will: a) determine the dose response for NAFLD/NAFLD mechanisms following sub-acute VC exposures and the impact of co-exposures with HF/LA diets, b) determine whether the ablation of OXLAMs via 12/15-LO genetic deficiency attenuates VC-induced liver inflammation and injury and the mechanisms involved. This work will be performed in vivo comparing wild-type (WT) to 12/15-LO knockout mice with complementary in vitro models that target 12/15-LO pharmacologically or genetically (e.g., primary cells derived from 12/15-LO KO mice). Mechanistic endpoints based on preliminary data will include mitochondrial dysfunction, hepatocyte death (necrosis vs. apoptosis), ER stress and metabolism/ bioenergetics impacting steatosis/cell survival. The aims of this R03 build on my K01 research and extend that project. However, here we are building on that foundation to leverage new questions in investigating the role of a specific fat type (and its oxidized metabolites) that is prevalent in the US. This focus is distinct and unique from my K01 research, but will complement it very aptly. This proposal is consistent with the goals of NIDDK to investigate the causes/consequences of obesity.
肥胖及其代谢并发症在美国非常普遍,是主要的健康问题 和世界各地。事实上,肥胖可能会影响个体对其他环境暴露的敏感性, 氯乙烯(VC)。具体来说,我们假设实验性NAFLD和某些类型的消费 膳食脂肪如多不饱和脂肪酸(PUFA)使肝脏对VC敏感,作为第二次打击。因此我们 提出LA代谢物通过分子、细胞器和细胞使肝脏对VC肝毒性敏感 VC效应(NAFLD机制)。目标1.评价OXLAM在VC增强的肝细胞死亡中的作用 在NAFLD的动物模型中。具体而言,我们将:a)确定NAFLD/NAFLD的剂量反应 亚急性VC暴露后的机制以及与HF/LA饮食共同暴露的影响,B)确定 通过12/15-LO基因缺陷消除OXLAMs是否能减弱VC诱导的肝脏炎症, 损伤及相关机制。这项工作将在体内进行,比较野生型(WT)与12/15-LO 用靶向12/15-LO β或遗传(例如, 来源于12/15-LO KO小鼠的原代细胞)。基于初步数据的机制终点将包括 线粒体功能障碍、肝细胞死亡(坏死vs.凋亡)、ER应激和代谢/生物能量学 影响脂肪变性/细胞存活。这个R 03的目标建立在我的K 01研究的基础上,并扩展了该项目。 然而,在这里,我们正在建立在这个基础上,利用新的问题来调查一个特定的 脂肪类型(及其氧化代谢产物),在美国普遍存在。这一点与我的K 01截然不同,独一无二 研究,但将补充它非常恰当。这一提议符合NIDDK调查 肥胖的原因/后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Juliane I Beier其他文献

Juliane I Beier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Juliane I Beier', 18)}}的其他基金

Vinyl chloride modifies the risk for nonalcoholic fatty liver disease
氯乙烯可降低非酒精性脂肪肝的风险
  • 批准号:
    10644029
  • 财政年份:
    2022
  • 资助金额:
    $ 4.37万
  • 项目类别:
Vinyl chloride modifies the risk for nonalcoholic fatty liver disease
氯乙烯可降低非酒精性脂肪肝的风险
  • 批准号:
    10503659
  • 财政年份:
    2022
  • 资助金额:
    $ 4.37万
  • 项目类别:
Enhancement of NAFLD risk by vinyl chloride: interaction of gut-liver-adipose axi
氯乙烯增加 NAFLD 风险:肠-肝-脂肪轴的相互作用
  • 批准号:
    8816090
  • 财政年份:
    2013
  • 资助金额:
    $ 4.37万
  • 项目类别:
Enhancement of NAFLD risk by vinyl chloride: interaction of gut-liver-adipose axi
氯乙烯增加 NAFLD 风险:肠-肝-脂肪轴的相互作用
  • 批准号:
    8641352
  • 财政年份:
    2013
  • 资助金额:
    $ 4.37万
  • 项目类别:
Enhancement of NAFLD risk by vinyl chloride: interaction of gut-liver-adipose axi
氯乙烯增加 NAFLD 风险:肠-肝-脂肪轴的相互作用
  • 批准号:
    9249527
  • 财政年份:
    2013
  • 资助金额:
    $ 4.37万
  • 项目类别:
Enhancement of NAFLD risk by vinyl chloride: interaction of gut-liver-adipose axi
氯乙烯增加 NAFLD 风险:肠-肝-脂肪轴的相互作用
  • 批准号:
    9023536
  • 财政年份:
    2013
  • 资助金额:
    $ 4.37万
  • 项目类别:
Enhancement of NAFLD risk by vinyl chloride: interaction of gut-liver-adipose axi
氯乙烯增加 NAFLD 风险:肠-肝-脂肪轴的相互作用
  • 批准号:
    8509411
  • 财政年份:
    2013
  • 资助金额:
    $ 4.37万
  • 项目类别:

相似海外基金

CAS: Collaborative Research: Ambient Polyvinyl Chloride (PVC) Upgrading Using Earth-Abundant Molecular Electrocatalysts
CAS:合作研究:使用地球上丰富的分子电催化剂升级常温聚氯乙烯 (PVC)
  • 批准号:
    2347912
  • 财政年份:
    2024
  • 资助金额:
    $ 4.37万
  • 项目类别:
    Standard Grant
CAS: Collaborative Research: Ambient Polyvinyl Chloride (PVC) Upgrading Using Earth-Abundant Molecular Electrocatalysts
CAS:合作研究:使用地球上丰富的分子电催化剂升级常温聚氯乙烯 (PVC)
  • 批准号:
    2347913
  • 财政年份:
    2024
  • 资助金额:
    $ 4.37万
  • 项目类别:
    Standard Grant
SBIR Phase II: Addressing Freshwater Salinization and Freshwater Scarcity with a Chloride Selective Removal and Recovery System
SBIR 第二阶段:通过氯化物选择性去除和回收系统解决淡水盐化和淡水短缺问题
  • 批准号:
    2321964
  • 财政年份:
    2024
  • 资助金额:
    $ 4.37万
  • 项目类别:
    Cooperative Agreement
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
  • 批准号:
    10354185
  • 财政年份:
    2023
  • 资助金额:
    $ 4.37万
  • 项目类别:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
  • 批准号:
    10367805
  • 财政年份:
    2023
  • 资助金额:
    $ 4.37万
  • 项目类别:
A Novel Gene Therapy Approach to Prevent Alpha-synuclein Misfolding in Multiple System Atrophy
一种防止多系统萎缩中α-突触核蛋白错误折叠的新基因治疗方法
  • 批准号:
    10673418
  • 财政年份:
    2023
  • 资助金额:
    $ 4.37万
  • 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
  • 批准号:
    10668167
  • 财政年份:
    2023
  • 资助金额:
    $ 4.37万
  • 项目类别:
Developing Tools to Understand an Alternative Fate of Urate in Neurodegenerative Diseases
开发工具来了解尿酸盐在神经退行性疾病中的替代命运
  • 批准号:
    10668103
  • 财政年份:
    2023
  • 资助金额:
    $ 4.37万
  • 项目类别:
Computer-aided design and development of isoform selective inhibitors of Casein Kinase 1
酪蛋白激酶 1 异构体选择性抑制剂的计算机辅助设计和开发
  • 批准号:
    10629703
  • 财政年份:
    2023
  • 资助金额:
    $ 4.37万
  • 项目类别:
Effect of High Salt Diet on Proximal Tubular Sodium Reabsorption, Metabolic Stress, and Injury
高盐饮食对近端肾小管钠重吸收、代谢应激和损伤的影响
  • 批准号:
    10908784
  • 财政年份:
    2023
  • 资助金额:
    $ 4.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了